title: [Tamsulosin administration for prophylaxis and treatment of stent-related symptoms].
abstract: The study of efficacy and safety of tamsulosin in therapy of stent-related symptoms has demonstrated that tamsulosin relieves stent-related irritative symptoms and improves quality of life. Further prospective trials are needed to finally assess tamsulosin efficacy.
authors.forename: A G
authors.initials: AG
authors.lastname: Martov
authors.forename: V A
authors.initials: VA
authors.lastname: Maksimov
authors.forename: D V
authors.initials: DV
authors.lastname: Ergakov
authors.forename: V M
authors.initials: VM
authors.lastname: Miroshnikov
authors.forename: F R
authors.initials: FR
authors.lastname: Asfandiiarov
authors.forename: E S
authors.initials: ES
authors.lastname: Kalashnikov
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D015607:Stents / Q000009:adverse effects*; D013449:Sulfonamides / Q000008:administration & dosage / Q000627:therapeutic use*; D011795:Surveys and Questionnaires; D000077409:Tamsulosin; D016896:Treatment Outcome; D014515:Ureteral Diseases / Q000601:surgery*; D014555:Urination Disorders / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control*; D014563:Urodynamics; D055815:Young Adult
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D013449:Sulfonamides; D000077409:Tamsulosin